Product category:
Cleaning products
News Release from: Gloster Sante Europe | Subject: Sterinis
Edited by the Laboratorytalk Editorial
Team on 12 January 2006
Ultra-high performance disinfection
Dry-fog diffusion technology and hydrogen peroxide-based disinfectant guarantees the extensive eradication of pathogenic microorganisms by disinfecting all surfaces, even if inaccessible or hidden
Combining a unique and patented dry-fog diffusion technology with ultra-high performance hydrogen peroxide-based disinfectant, the innovative Sterinis process meets all the requirements of the biocide directive CE 98/8 It guarantees the extensive eradication of pathogenic microorganisms by disinfecting all surfaces, even those which are inaccessible or hidden
This article was originally published on Laboratorytalk on 20 Jan 2006 at 8.00am (UK)
Related stories
Sterinis achieves ultra-high success worldwide
Sterinis constitutes an ultra-high-performance disinfection technology suitable for all surfaces, including those which are inaccessible or hidden
Quantitated PCR control DNA for H pylori
Detection of H pylori by PCR assay has a sensitivity of up to 93%, with a specificity of 100% when compared to microbiologic culture and histologic examination of biopsy tissues
It thus makes it possible to guard against contaminations and infections, especially nosocomial infections.
It unites effectiveness with safety and a considerable reduction in disinfection costs.
In the past year the system's developer, Gloster Sante Europe, doubled its international distribution network.
Further reading
Quantitated PCR control DNA for polyomaviruses
Both JCV and BKV infections are transmitted from human to human (probably through the respiratory system), establish viremia, settle in the kidneys and remain latent in the host
Quantitated PCR control DNA for SV 40
Simian virus 40 is suspected to be a carcinogen, and is estimated to infect up to 30 million people in the USA as the result of contaminated polio vaccine used in the 1950s and 60s
Reagent kits optimised for array platform
These reagents offer a complete, standardised sample preparation system that is easier to use and will help customers produce more robust and consistent array results
Sterinis integrates a one-of-its-kind traceability system which enables all disinfecting operations to be recorded with a data log available via the USB port.
Its automatic monitoring and simple operating systems make it perfectly adapted for use by non-specialised personnel.
It also allows for savings to be generated.
This disinfection technology requires no human presence and shortens the amount of downtime for rooms undergoing treatment.
Almost instantly, this process has made its mark as an indispensable tool in global hygiene protocols.
Canon Brittany, which has an industrial partnership agreement with Gloster Sante Europe, has manufactured Sterinis since November 2004.
The experience and worldwide organisation of Canon guarantee the products a very high level of quality and logistics optimisation.
Currently distributed in 17 countries with 14 more awaiting approval, it is used by renowned hospitals, clinics, and laboratories across Europe, North Africa, and the Middle East for prevention and treatment purposes.
This success follows its international scientific recognition, a coherent marketing policy, as well as perfect cooperation between Gloster Sante Europe and its distributors.
The Sterinis disinfection process has convinced a very large number of decision-makers in the fields of hospital care, pharmaceuticals, and food business.
The results of the tests carried out under both laboratory conditions and actual hospital usage conditions (operating theatre suites, recovery rooms, infectious diseases rooms, dental surgeries, etc) in France and abroad (Norway, Denmark, Holland, Ireland, Taiwan, Turkey, etc) cannot be disputed.
Sterinis is one of the highest performing disinfection processes on the market, says Gloster Sante Europe.
Sterinis complies with the NF harmonised standards as well as the CE directives, among which the Afnor standard NF T 72-281 and the biocide directive CE 98/8.
Moreover, Gloster Sante Europe has ISO 9001:2000 and ISO 13485:2003 certification awarded by SGS Yarsley, a Ukas accredited body.
Sterinis is neither corrosive nor toxic and is 99.99% biodegradable.
All assessment reports can be downloaded.
Gloster Sante Europe will be presenting Sterinis at the following trade shows in 2006: ECCMID (European Congress of Clinical Microbiology and Infectious Diseases) in Nice 1-4 April (Acropolis Congress Centre); Hopital Expo - Intermedica in Paris (Porte de Versailles) 16-19 May; Afstal in Bordeaux (Palais des Congres) 31 May - 2 June; Sipec (Pharmaceuticals and Cosmetics Industries Trade Fair) in Orleans (Palais des Congres) 12-14 September; and Medica 2006 in Dusseldorf, Germany, in November.
• Gloster Sante Europe: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
